Phase II Trial of Gemcitabine, Cisplatin, and Sunitinib in Patients With Advanced/Metastatic Urothelial Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Sunitinib (Primary) ; Cisplatin; Gemcitabine
- Indications Bladder cancer; Urogenital cancer
- Focus Therapeutic Use
- 20 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Jun 2011 Planned End Date changed from 1 Jun 2010 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 06 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.